Radiation Therapy Noncompliance Impairs Tumor Control
By MedImaging International staff writers Posted on 17 Feb 2016 |
A new study concludes that the interruption of sequential external beam radiation therapy (RT) appointments may impair tumor control, particularly for head and neck cancers.
Researchers at the Montefiore Einstein Center for Cancer Care (MECCC; New York, NY, USA) and Albert Einstein College of Medicine (New York, NY, USA) conducted a study that evaluated 1,227 patients between 2007 and 2012 who were scheduled for courses of external beam RT for cancers of the head and neck, breast, lung, cervix uterus, or rectum. In all, 21.7% of the patients were noncompliant, missing two or more scheduled therapy appointments, but all patients eventually completed the radiation therapy course planned for them.
The results showed that at median follow-up of 50.9 months, 108 recurrences (8.8%) and 228 deaths (18.6%) occurred. Despite the average one week delay in noncompliant patient RT completion, 16% of the noncompliant patients experienced a recurrence, versus only a 7% recurrence rate in compliant patients. According to the researchers, noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes. The study was published in January 2016 issue of the International Journal of Radiation Oncology Biology Physics.
“This study shows that the health of our patients can improve only when a course of treatment is completed in the prescribed period of time,” said senior author Prof. Madhur Garg, MD, clinical director of the department of Radiation Oncology at MECCC. “These findings should serve as a wakeup call to physicians, patients and their caregivers about the critical need to adhere to a recommended treatment schedule.”
“We previously conducted a study that demonstrated a statistically significant relationship between lower socioeconomic status and non-compliance,” said lead author Nitin Ohri, MD, assistant professor of radiation oncology at Albert Einstein College of Medicine. “As an outcome result of this study, management of mood disorders, patient navigator programs, and increasing assistance with transportation are being evaluated at Montefiore as interventions that might improve patient care outcomes and close disparities among vulnerable populations.”
Prolonging radiation therapy for head and neck cancer or cervical cancer can impact tumor control and overall survival at a rate of one percent per day, which is attributed to tumor repopulation. The repopulation can even accelerate after treatment initiation.
Related Links:
Montefiore Einstein Center for Cancer Care
Albert Einstein College of Medicine
Researchers at the Montefiore Einstein Center for Cancer Care (MECCC; New York, NY, USA) and Albert Einstein College of Medicine (New York, NY, USA) conducted a study that evaluated 1,227 patients between 2007 and 2012 who were scheduled for courses of external beam RT for cancers of the head and neck, breast, lung, cervix uterus, or rectum. In all, 21.7% of the patients were noncompliant, missing two or more scheduled therapy appointments, but all patients eventually completed the radiation therapy course planned for them.
The results showed that at median follow-up of 50.9 months, 108 recurrences (8.8%) and 228 deaths (18.6%) occurred. Despite the average one week delay in noncompliant patient RT completion, 16% of the noncompliant patients experienced a recurrence, versus only a 7% recurrence rate in compliant patients. According to the researchers, noncompliance to scheduled treatments may represent a new behavioral biomarker for identifying high-risk patients who require additional interventions to achieve optimal care outcomes. The study was published in January 2016 issue of the International Journal of Radiation Oncology Biology Physics.
“This study shows that the health of our patients can improve only when a course of treatment is completed in the prescribed period of time,” said senior author Prof. Madhur Garg, MD, clinical director of the department of Radiation Oncology at MECCC. “These findings should serve as a wakeup call to physicians, patients and their caregivers about the critical need to adhere to a recommended treatment schedule.”
“We previously conducted a study that demonstrated a statistically significant relationship between lower socioeconomic status and non-compliance,” said lead author Nitin Ohri, MD, assistant professor of radiation oncology at Albert Einstein College of Medicine. “As an outcome result of this study, management of mood disorders, patient navigator programs, and increasing assistance with transportation are being evaluated at Montefiore as interventions that might improve patient care outcomes and close disparities among vulnerable populations.”
Prolonging radiation therapy for head and neck cancer or cervical cancer can impact tumor control and overall survival at a rate of one percent per day, which is attributed to tumor repopulation. The repopulation can even accelerate after treatment initiation.
Related Links:
Montefiore Einstein Center for Cancer Care
Albert Einstein College of Medicine
Latest Radiography News
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more